vs
Side-by-side financial comparison of Pulmonx Corp (LUNG) and Snail, Inc. (SNAL). Click either name above to swap in a different company.
Snail, Inc. is the larger business by last-quarter revenue ($25.1M vs $20.6M, roughly 1.2× Pulmonx Corp). Snail, Inc. runs the higher net margin — -3.4% vs -66.3%, a 62.9% gap on every dollar of revenue. On growth, Snail, Inc. posted the faster year-over-year revenue change (-4.2% vs -8.7%). Over the past eight quarters, Snail, Inc.'s revenue compounded faster (33.4% CAGR vs -0.5%).
Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.
Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....
LUNG vs SNAL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.6M | $25.1M |
| Net Profit | $-13.7M | $-862.2K |
| Gross Margin | 77.9% | 38.3% |
| Operating Margin | -40.9% | -6.0% |
| Net Margin | -66.3% | -3.4% |
| Revenue YoY | -8.7% | -4.2% |
| Net Profit YoY | 5.5% | -177.0% |
| EPS (diluted) | $-0.33 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $20.6M | — | ||
| Q4 25 | $22.6M | $25.1M | ||
| Q3 25 | $21.5M | $13.8M | ||
| Q2 25 | $23.9M | $22.2M | ||
| Q1 25 | $22.5M | $20.1M | ||
| Q4 24 | $23.8M | $26.2M | ||
| Q3 24 | $20.4M | $22.5M | ||
| Q2 24 | $20.8M | $21.6M |
| Q1 26 | $-13.7M | — | ||
| Q4 25 | $-10.4M | $-862.2K | ||
| Q3 25 | $-14.0M | $-7.9M | ||
| Q2 25 | $-15.2M | $-16.6M | ||
| Q1 25 | $-14.4M | $-1.9M | ||
| Q4 24 | $-13.2M | $1.1M | ||
| Q3 24 | $-14.1M | $235.1K | ||
| Q2 24 | $-15.3M | $2.3M |
| Q1 26 | 77.9% | — | ||
| Q4 25 | 77.6% | 38.3% | ||
| Q3 25 | 74.7% | 0.1% | ||
| Q2 25 | 72.1% | 31.3% | ||
| Q1 25 | 72.5% | 29.1% | ||
| Q4 24 | 74.0% | 43.3% | ||
| Q3 24 | 73.7% | 38.6% | ||
| Q2 24 | 73.7% | 37.5% |
| Q1 26 | -40.9% | — | ||
| Q4 25 | -43.8% | -6.0% | ||
| Q3 25 | -66.9% | -71.3% | ||
| Q2 25 | -62.0% | -8.2% | ||
| Q1 25 | -64.6% | -20.4% | ||
| Q4 24 | -56.5% | 11.5% | ||
| Q3 24 | -69.3% | 1.8% | ||
| Q2 24 | -75.2% | 12.4% |
| Q1 26 | -66.3% | — | ||
| Q4 25 | -46.1% | -3.4% | ||
| Q3 25 | -64.9% | -56.9% | ||
| Q2 25 | -63.6% | -74.7% | ||
| Q1 25 | -64.1% | -9.7% | ||
| Q4 24 | -55.4% | 4.3% | ||
| Q3 24 | -69.4% | 1.0% | ||
| Q2 24 | -73.7% | 10.4% |
| Q1 26 | $-0.33 | — | ||
| Q4 25 | $-0.25 | — | ||
| Q3 25 | $-0.34 | — | ||
| Q2 25 | $-0.38 | $-0.44 | ||
| Q1 25 | $-0.36 | $-0.06 | ||
| Q4 24 | $-0.33 | $0.03 | ||
| Q3 24 | $-0.36 | $0.01 | ||
| Q2 24 | $-0.39 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $61.6M | $8.6M |
| Total DebtLower is stronger | $37.3M | $14.6M |
| Stockholders' EquityBook value | $45.8M | $-16.4M |
| Total Assets | $120.0M | $59.3M |
| Debt / EquityLower = less leverage | 0.82× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.6M | — | ||
| Q4 25 | $69.8M | $8.6M | ||
| Q3 25 | $76.5M | $12.3M | ||
| Q2 25 | $75.5M | $7.9M | ||
| Q1 25 | $74.6M | $9.4M | ||
| Q4 24 | $70.9M | $7.3M | ||
| Q3 24 | $63.3M | $10.6M | ||
| Q2 24 | $63.5M | $15.5M |
| Q1 26 | $37.3M | — | ||
| Q4 25 | $37.1M | $14.6M | ||
| Q3 25 | $37.1M | $10.5M | ||
| Q2 25 | $37.1M | $11.8M | ||
| Q1 25 | $37.2M | $9.0M | ||
| Q4 24 | $37.2M | $5.7M | ||
| Q3 24 | $37.2M | $5.7M | ||
| Q2 24 | $37.2M | $5.8M |
| Q1 26 | $45.8M | — | ||
| Q4 25 | $54.1M | $-16.4M | ||
| Q3 25 | $60.0M | $-15.6M | ||
| Q2 25 | $69.1M | $-8.0M | ||
| Q1 25 | $77.7M | $9.1M | ||
| Q4 24 | $85.8M | $9.7M | ||
| Q3 24 | $93.9M | $8.2M | ||
| Q2 24 | $101.2M | $7.9M |
| Q1 26 | $120.0M | — | ||
| Q4 25 | $129.3M | $59.3M | ||
| Q3 25 | $138.3M | $51.1M | ||
| Q2 25 | $147.2M | $58.0M | ||
| Q1 25 | $150.7M | $64.5M | ||
| Q4 24 | $162.8M | $62.2M | ||
| Q3 24 | $167.4M | $66.8M | ||
| Q2 24 | $172.6M | $75.4M |
| Q1 26 | 0.82× | — | ||
| Q4 25 | 0.69× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.48× | 0.99× | ||
| Q4 24 | 0.43× | 0.59× | ||
| Q3 24 | 0.40× | 0.70× | ||
| Q2 24 | 0.37× | 0.73× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-5.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $-5.3M | ||
| Q3 25 | $-8.2M | $6.6M | ||
| Q2 25 | $-3.9M | $-3.2M | ||
| Q1 25 | $-13.2M | $764.5K | ||
| Q4 24 | $-6.7M | $-3.6M | ||
| Q3 24 | $-7.2M | $-5.0M | ||
| Q2 24 | $-5.8M | $206.6K |
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | — | ||
| Q3 25 | $-8.3M | — | ||
| Q2 25 | $-4.0M | — | ||
| Q1 25 | $-13.5M | — | ||
| Q4 24 | $-6.8M | — | ||
| Q3 24 | $-7.7M | — | ||
| Q2 24 | $-6.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | -31.4% | — | ||
| Q3 25 | -38.4% | — | ||
| Q2 25 | -16.6% | — | ||
| Q1 25 | -60.0% | — | ||
| Q4 24 | -28.8% | — | ||
| Q3 24 | -37.6% | — | ||
| Q2 24 | -30.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.21× | ||
| Q3 24 | — | -21.05× | ||
| Q2 24 | — | 0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LUNG
Segment breakdown not available.
SNAL
| Pc | $14.7M | 59% |
| Platform Three | $5.2M | 21% |
| Platform Two | $3.3M | 13% |
| Sales Channel Directly To Consumer Mobile Sale | $1.6M | 6% |
